| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.6 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.031 | 0.6 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.6 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |